Le Lézard
Classified in: Health
Subject: MRR

Webinar on Healthcare Innovations for Sustainable Future by Kalkine Media on October 21, 2021


SYDNEY, Oct. 16, 2021 /PRNewswire/ -- Ensuring healthy lives and promoting physical and mental well-being is essential to sustainable development. Currently, the world is facing a global health crisis unlike any other. Global health has increasingly gained international visibility and prominence. From big data to precision medicine, the recent advances in biomedical research have swept away the conventional approach to medical science. The availability of large volumes of digitised clinical data, combined with powerful artificial intelligence (AI) algorithms, are proving to be the real gamechangers. 

Kalkine Logo (PRNewsfoto/Kalkine Ltd.)

Get insights on Healthcare Innovations from three of our valued clients, who are leaders in the Australian healthcare and biotech space. Managing Director and Chief Executive Officer of Cynata Therapeutics Limited - Dr Ross Macdonald, Executive Chair and CEO of Invion Limited - Mr. Thian Chew, and CEO & Managing Director of PainChek Limited Mr. Philip Daffas.

The webinar will help potential investors get a sense of how the healthcare sector looks like in the future in an exclusive Invest Nest Webinar by Kalkine Media. 

Cynata Therapeutics Limited is an Australian-based clinical-stage stem cell and regenerative medicine company, based in Cubitt Street, Cremorne, Victoria. The Company focusses on the development of therapies based on its unique Cymerustm technology. The Company's Cymerustm technology is addressing a critical limitation in existing MSCs (mesenchymal stem cells) production methods for therapeutic use.

Australian life sciences company Invion Limited is dedicated to transforming Photodynamic Therapy (PDT) to develop innovative and effective cancer treatments. The firm is leading the global clinical development of PhotosoftTM technology, which is an improved next-generation Photodynamic Therapy.

PainChek Limited engages in the development and commercialisation of mobile medical device applications. These device applications automate intelligent pain assessment of individuals who are unable to communicate their pain with carers. The journey of PainChek began in 2016. Since then, PainChek has come a long way with several core goals achieved. PainChek envisions to emerge as a leader in the market for innovative pain assessment products while providing services to help enhance the quality of life for people suffering from pain.

About Kalkine Media 
Kalkine Media operates across Australia, New Zealand, Canada, UK and the US. It aims to keep its readers abreast of the latest and trending news on the equity and commodity markets, the unravelling economy and other business developments. 

Please register on- https://kalkinemedia.com/webinar/register/88308413557?utm_source=press_release&utm_medium=organic&utm_campaign=invest-nest-webinar-by-kalkine-media-healthcare-innovations-for-sustainable-future

Logo - https://mma.prnewswire.com/media/1341740/Kalkine_Logo.jpg

 


These press releases may also interest you

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:08
Aesthetic Management Partners LLC, a manufacturer of skin-based solutions and a provider of energy-based devices announces its collaboration with Croma (Croma-Pharma® GmbH), a global player in the minimally invasive aesthetics market and a leading...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...

at 06:00
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to...



News published on and distributed by: